BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33938067)

  • 1. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
    Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
    Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
    Federico A; Thomas C; Miskiewicz K; Woltering N; Zin F; Nemes K; Bison B; Johann PD; Hawes D; Bens S; Kordes U; Albrecht S; Dohmen H; Hauser P; Keyvani K; van Landeghem FKH; Lund EL; Scheie D; Mawrin C; Monoranu CM; Parm Ulhøi B; Pietsch T; Reinhard H; Riemenschneider MJ; Sehested A; Sumerauer D; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Acta Neuropathol; 2022 Jun; 143(6):697-711. PubMed ID: 35501487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
    Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
    Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
    Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
    Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
    Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and
    Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T
    Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
    Ho B; Johann PD; Grabovska Y; De Dieu Andrianteranagna MJ; Yao F; Frühwald M; Hasselblatt M; Bourdeaut F; Williamson D; Huang A; Kool M
    Neuro Oncol; 2020 May; 22(5):613-624. PubMed ID: 31889194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor.
    Nowak J; Nemes K; Hohm A; Vandergrift LA; Hasselblatt M; Johann PD; Kool M; Frühwald MC; Warmuth-Metz M
    Neuro Oncol; 2018 Nov; 20(12):1672-1679. PubMed ID: 30010851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
    Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
    Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006.
    Fleming AJ; Hukin J; Rassekh R; Fryer C; Kim J; Stemmer-Rachamimov A; Birks DK; Huang A; Yip S; Dunham C
    Brain Pathol; 2012 Sep; 22(5):625-35. PubMed ID: 22188464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
    Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.
    Chun HE; Johann PD; Milne K; Zapatka M; Buellesbach A; Ishaque N; Iskar M; Erkek S; Wei L; Tessier-Cloutier B; Lever J; Titmuss E; Topham JT; Bowlby R; Chuah E; Mungall KL; Ma Y; Mungall AJ; Moore RA; Taylor MD; Gerhard DS; Jones SJM; Korshunov A; Gessler M; Kerl K; Hasselblatt M; Frühwald MC; Perlman EJ; Nelson BH; Pfister SM; Marra MA; Kool M
    Cell Rep; 2019 Nov; 29(8):2338-2354.e7. PubMed ID: 31708418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical teratoid/rhabdoid tumors of childhood].
    Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
    Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.